INTRODUCTION “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162b2) Received Through 28-Feb-2021,” Pfizer’s post-marketing report, a required U.S. Food and Drug Administration (FDA) compliance document, is one of the ways in which the FDA assessed patients’ risks associated with Pfizer’s COVID-19 vaccine, BNT162b2. The data within the […]
“To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older” – Latest version (submitted July 14, 2023) on ClinicalTrials.gov
“The Safety of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older,” eh? Hmm. I was under the impression that if you are pregnant, or hoping to be, you shouldn’t do certain things like drink alcohol, smoke cigarettes, and get injected with experimental transfecting agents. You […]
Hot Lots: “Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine” by Schmeling et al.
Dr. John Campbell discusses a March 2023 Danish research paper with one of the paper’s authors, Dr. Vibeke Manniche. The paper demonstrates that early batches of COVID-19 “vaccines” were associated with very high levels of adverse events. Dr. Manniche’s research letter can be found here: https://onlinelibrary.wiley.com/doi/10.1111/eci.13998. (Schmeling, Max, et al. […]